Specific inhibition of MET phosphorylation with small molecule inhibitors has demonstrated the capacity of counteracting the HGF induced effects in SCLC and other tumour models (Christensen et al, 2003; Ma et al, 2005; Zou et al, 2007). The gene discussed is MET; the disease is neoplasm.